Profile data is unavailable for this security.
About the company
PT Kimia Farma Tbk is an Indonesia-based company, which is engaged in producing, distributing, and marketing chemical industry product, active pharmaceutical ingredients (API) and high function chemicals (HFC). Its segments include Manufacturing, Distribution, Retail, and Other. The Manufacturing segment includes chemical and pharmaceutical manufacturing, research and development, and manufacturing marketing and marketing of quinine and essential oils; manufacturing and marketing of active pharmaceutical ingredients and HFC, and manufacturing and marketing of pharmaceutical products. The distribution segment is engaged in distribution of pharmaceutical products to domestic market and to the international market, including Saudi Arabia, the United States, Netherlands, the United Kingdom, China, Malaysia, and several other countries. The Retail segment is engaged in the sale of medicines and pharmaceutical products directly to customers.
- Revenue in IDR (TTM)10.19tn
- Net income in IDR-151.01bn
- Incorporated1971
- Employees11.56k
- LocationKimia Farma Tbk PTJalan Veteran No. 9JAKARTA 10110IndonesiaIDN
- Phone+62 2 138477709
- Fax+62 213454338
- Websitehttps://www.kimiafarma.co.id
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbisko Cayman Ltd | 42.59bn | -964.27bn | 4.15tn | 252.00 | -- | 0.9371 | -- | 97.40 | -0.7214 | -0.7214 | 0.0319 | 3.05 | 0.0083 | -- | -- | -- | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
| Cutia Therapeutics | 307.49bn | -4.39tn | 4.24tn | 298.00 | -- | 1.40 | -- | 13.80 | -18.28 | -18.28 | 0.7276 | 4.80 | -- | -- | -- | 499,580.00 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| SinoMab Bioscience Ltd | 3.05bn | -543.18bn | 4.28tn | 233.00 | -- | 6.15 | -- | 1,404.81 | -0.2583 | -0.2583 | 0.0015 | 0.309 | 0.0015 | -- | -- | -- | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -8.15 | 0.604 | -- | -- | -- | 14.45 | -- | -- | -- |
| Panion & BF Biotech Inc | 936.98bn | 38.45bn | 4.31tn | 321.00 | 112.21 | 4.53 | 34.97 | 4.60 | 0.9001 | 0.9001 | 21.94 | 22.29 | 0.5947 | 1.67 | 8.19 | -- | 2.44 | 4.08 | 3.55 | 5.63 | 51.78 | 52.37 | 4.10 | 5.93 | 0.8931 | 16.24 | 0.2758 | 111.06 | -21.54 | 5.96 | -57.65 | -13.47 | 35.39 | -3.23 |
| Immutep Ltd | 2.67bn | -420.65bn | 4.32tn | 19.00 | -- | 3.60 | -- | 1,621.43 | -0.0394 | -0.0394 | 0.0003 | 0.0973 | 0.0025 | -- | 2.48 | -- | -38.61 | -36.31 | -41.57 | -39.21 | -- | -- | -15,782.59 | -919.13 | -- | -- | 0.0138 | -- | -24.64 | -51.34 | -23.86 | -- | 47.40 | -- |
| Opthea Ltd | 1.89bn | -2.61tn | 4.34tn | 5.00 | -- | -- | -- | 2,294.32 | -0.4814 | -0.4814 | 0.0004 | -0.11 | 0.0007 | -- | 0.1772 | -- | -100.84 | -90.04 | -116.05 | -100.93 | -99.74 | -197.19 | -138,008.10 | -69,641.71 | -- | -29.64 | 1.35 | -- | 19.55 | -34.31 | -53.55 | -- | -3.82 | -- |
| Shanghai Shen Lian Biomedical Corp | 628.87bn | 57.78bn | 4.35tn | 365.00 | 75.27 | 1.30 | -- | 6.92 | 0.063 | 0.063 | 0.6854 | 3.66 | 0.1731 | 0.7474 | 0.9025 | 771,056.40 | 1.54 | 6.85 | 1.65 | 7.54 | 70.64 | 79.21 | 8.92 | 29.63 | 6.58 | -- | 0.0008 | 30.78 | -8.32 | 1.70 | -44.56 | -9.14 | -2.08 | -- |
| Hanshang Group Co Ltd | 3.08tn | 205.00bn | 4.36tn | 2.11k | 21.21 | 1.16 | -- | 1.42 | 0.3121 | 0.3121 | 4.69 | 5.73 | 0.3993 | 2.33 | 7.25 | 655,279.10 | 2.40 | 2.09 | 3.79 | 4.33 | 59.05 | 51.52 | 6.00 | 4.66 | 0.4033 | 2.20 | 0.3406 | 19.99 | -5.98 | 6.50 | 3.27 | 39.98 | 18.19 | 21.06 |
| Kimia Farma Tbk PT | 10.19tn | -151.01bn | 4.37tn | 11.56k | -- | 0.5423 | 7.13 | 0.4289 | -27.14 | -29.92 | 1,832.23 | 1,447.63 | 0.5197 | 1.99 | 4.03 | 875,986,400.00 | -0.2064 | 0.9731 | -0.3699 | 1.62 | 38.10 | 36.45 | -0.3972 | 1.52 | 0.5765 | 1.25 | 0.4588 | -- | -25.29 | 9.41 | -151.14 | -- | -4.56 | -- |
